v3.22.2.2
Additional paid-in capital
6 Months Ended
Jun. 30, 2022
Additional Paid-in Capital  
Additional paid-in capital

7.        Additional paid-in capital

 

Stock options

 

A summary of stock option activity is as follows:

 

           
 

Six Months Ended

June 30, 2022

Year Ended

December 31, 2021

  Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price
Outstanding, beginning of period 5,497,001,500 $ 0.006 5,362,701,500 $ 0.004
Granted - $ - 165,000,000 $ 0.050
Exercised - $ - (800,000) $ (0.015)
Cancelled (90,000,000) $ (0.041) (29,900,000) $ (0.034)
Outstanding, end of period 5,407,001,500 $ 0.005 5,497,001,500 $ 0.006
             
Exercisable, end of period 5,223,701,500 $ 0.004 5,221,701,500 $ 0.004

 

During the period ended June 30, 2022:

 

On March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending the vesting period under vesting terms, which have not been met, from September 30, 2021 and December 31, 2021 to December 31, 2022, and from June 30, 2022 to June 30, 2023.

 

On March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October 4, 2021 by vesting 1,000,000 options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended June 30, 2022, $59,639 related to the 1,000,000 options that vested immediately was recorded.

 

Effective March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035 and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.

 

On April 27, 2022, the Company provided termination notice to a contractor. As a result, the contractor’s 30,000,000 stock options exercisable at $0.05 were cancelled, unvested, effective June 30, 2022.

 

During the period ended June 30, 2022, the Company recorded a total of $518,659 in compensation expense related to the vesting of stock options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.

 

During the year ended December 31, 2021:

 

On January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares of common stock will expire December 31, 2025, and options to acquire 10,000,000 shares of common stock will expire May 17, 2024. As at June 30, 2022, 2,000,000 (December 31, 2021 - 1,000,000) options have vested to date. The fair value of the options granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952 relates to stock options that have performance vesting conditions. During the period ended June 30, 2022, $98,726 (December 31, 2021 - $248,189) related to stock options with time-based vesting conditions and $56,648 (December 31, 2021 - $nil) related to stock options with performance-based vesting conditions was recognized. The remaining fair value of $1,302,681 has not been recorded.

 

On February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share. These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The fair value of the options granted totaled $225,141. During the period ended June 30, 2022, $34,638 (December 31, 2021 - $57,730) related to stock options with time-based vesting conditions was recognized. The remaining fair value of $132,773 has not been recorded.

 

On April 14, 2021, the Company’s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of common stock at a price of $0.05 per share until December 31, 2025 to five individuals. All of the options will vest according to performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812, of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have performance vesting conditions. During the period ended June 30, 2022, $54,558 (December 31, 2021 - $88,540) related to the stock options with time-based vesting conditions was recognized. The remaining fair value of $1,422,714 has not been recorded.

 

On May 12, 2021, the Company’s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28, 2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares of common stock at a price of $0.05 per share until December 31, 2025. All other terms of the January 28, 2021 grant remain the same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.

 

On May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of $0.05 per share until December 31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled $254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.

 

 

On June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.

 

On June 27, 2021, the Company’s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common stock at a price of $0.05 per share until June 30, 2026 to four individuals. All of the options will vest according to performance or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended June 30, 2022, $9,812 (December 31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining fair value of $1,354,580 has not been recorded.

 

On June 30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July 1, 2016 by extending the expiry date from July 1, 2021 to April 12, 2024. The options were granted in connection with lines of credit provided by the Chairman and his spouse, which are currently outstanding (note 5). All of the options had vested in previous years. The fair value of the amendments totaled $1,287,834 and was recorded during the year ended December 31, 2021 in interest expense.

 

Effective July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors and advisors.

 

On August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price of $0.05 per share until June 30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.

 

On October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05 per share until September 30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest according to performance conditions. On March 18, 2022, the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. As at June 30, 2022, 1,000,000 (December 31, 2021 - nil) options have vested to date. The fair value of the options granted totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock options that have performance vesting conditions. During the period ended June 30, 2022, $204,638 (December 31, 2021 - $101,758) related to stock options with time-based vesting conditions and $59,639 (December 31, 2021 - $nil) related to stock options with performance-based vesting conditions was recognized. The remaining fair value of $677,655 has not been recorded.

 

On December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price of $0.05 per share until December 31, 2026 in connection with receiving line of credit financing (note 5). The fair value of the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.

 

On December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price of $0.05 per share until December 31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled $534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.

 

During the year ended December 31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock options granted in previous years.

 

Outstanding:

 

The options outstanding at June 30, 2022 and December 31, 2021 were as follows:

 

                   
  June 30, 2022 December 31, 2021
Expiry Date Options Exercise Price Intrinsic Value Options Exercise Price Intrinsic Value
                     
November 27, 2022 5,600,000 $ 0.015 $ 0.044 5,600,000 $ 0.015 $ 0.045
January 31, 2023 20,500,000 $ 0.015 $ 0.044 40,500,000 $ 0.015 $ 0.045
June 13, 2023 5,000,000 $ 0.015 $ 0.044 5,000,000 $ 0.015 $ 0.045
March 14, 2024 6,650,000 $ 0.035 $ 0.024 6,650,000 $ 0.035 $ 0.025
April 12, 2024 4,925,001,500 $ 0.002 $ 0.057 4,925,001,500 $ 0.002 $ 0.058
April 12, 2024 3,350,000 $ 0.015 $ 0.044 3,350,000 $ 0.015 $ 0.045
April 12, 2024 200,000 $ 0.030 $ 0.029 200,000 $ 0.030 $ 0.030
May 6, 2024 13,000,000 $ 0.035 $ 0.024 13,000,000 $ 0.035 $ 0.025
May 17, 2024 57,000,000 $ 0.050 $ 0.009 77,000,000 $ 0.050 $ 0.010
May 17, 2024 19,400,000 $ 0.035 $ 0.024 19,400,000 $ 0.035 $ 0.025
June 17, 2024 - $ - $ - 5,000,000 $ 0.050 $ 0.010
August 16, 2024 - $ - $ - 2,500,000 $ 0.050 $ 0.010
September 6, 2024 - $ - $ - 1,000,000 $ 0.050 $ 0.010
October 3, 2024 3,500,000 $ 0.035 $ 0.024 3,500,000 $ 0.035 $ 0.025
October 24, 2024 2,000,000 $ 0.035 $ 0.024 2,000,000 $ 0.035 $ 0.025
December 11, 2024 120,000,000 $ 0.015 $ 0.044 120,000,000 $ 0.015 $ 0.045
April 1, 2025 10,000,000 $ 0.035 $ 0.024 10,000,000 $ 0.035 $ 0.025
May 31, 2025 10,000,000 $ 0.035 $ 0.024 20,000,000 $ 0.035 $ 0.025
May 31, 2025 57,300,000 $ 0.050 $ 0.009 87,300,000 $ 0.050 $ 0.010
December 31, 2025 56,500,000 $ 0.050 $ 0.009 56,500,000 $ 0.050 $ 0.010
June 30, 2026 26,000,000 $ 0.050 $ 0.009 26,000,000 $ 0.050 $ 0.010
September 30, 2026 16,000,000 $ 0.050 $ 0.009 17,500,000 $ 0.050 $ 0.010
December 31, 2026 50,000,000 $ 0.050 $ 0.009 50,000,000 $ 0.050 $ 0.010
Total 5,407,001,500 $ 0.005 $ 0.053 5,497,001,500 $ 0.006 $ 0.054
                     
Weighted Average Remaining Contractual Life     1.87         2.37    

 

 

The fair value of the stock options granted and vested was allocated as follows:

 

                    
  

Three Months Ended

June 30, 2022

 

Three Months Ended

June 30, 2021

 

Six Months Ended

June 30, 2022

 

Six Months Ended

June 30, 2021

Interest expense  $     $1,287,834   $     $1,287,834 
Product development expense   56,418    61,697    118,586    97,842 
Professional expense   8,957    28,070    17,916    43,295 
Selling, general and administrative expenses   133,495          382,157       
                     
 Fair value of the stock options granted  $198,870   $1,377,601   $518,659   $1,428,971 

 

The Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:

 

          
  

June 30,

2022

 

December 31,

2021

Risk-free interest rate   N/A    0.87%
Expected life   N/A    4.8 years 
Expected dividends   N/A    0%
Expected volatility   N/A    278%
Forfeiture rate   N/A    0%

 

There were no options granted during the six months ended June 30, 2022. The weighted average fair value for the options granted during the year ended December 31, 2021 was $0.06.